Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
A new study indicates that high doses of fish oil supplementation fails to prevent the recurrence of atrial fibrillation.
When association is association and causation is causation.
Updated guidelines for postoperative atrial fibrillation contain several pieces of information for pharmacists to help prevent medication errors.
Latest Issues
$auto_registration$